Albuminuria/epidemiology; Europe/epidemiology; Humans; Hyperlipidemias/epidemiology; Hypertension/epidemiology; Insulin Resistance; Metabolic Syndrome X/epidemiology; North America/epidemiology; Obesity/epidemiology; Terminology as Topic
Abstract :
[en] The metabolic syndrome is strongly related to visceral obesity and associated with a high risk of cardiovascular morbidity and mortality. Since the original description of Reaven in 1988, several working definitions have been proposed, especially by the World Health Organisation in 1998-99, the National Cholesterol Education Program (NCEP-ATP III) Expert Panel in the United States in 2001 and the European Group for the Study of Insulin Resistance (EGIR) in 2002. The present paper attempts at comparing these various definitions and at reporting epidemiological data both in North America and in Europe, especially in Belgium. The prevalence is generally higher in men than in women and strongly increases with age. Overall, one may estimate that around 20% of adults have a metabolic syndrome, which should therefore be considered as an important public health problem.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Scheen, André ; Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale
Luyckx, Françoise ; Centre Hospitalier Universitaire de Liège - CHU > Chimie médicale
Language :
French
Title :
Le syndrome metabolique: definitions et donnees epidemiologiques.
Alternative titles :
[en] Metabolic syndrome: definitions and epidemiological data
Publication date :
2003
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Université de Liège. Revue Médicale de Liège, Liège, Belgium
Kylin E. - Studien über das Hypertonie-Hyperglykä mie-Hyperurikämiesyndrom. Zentralblatt fuer Innere Medizin, 1923, 44, 105-127.
Vague J. - The degree of masculine differentiation of obesities. A factor determining predisposition to diabetes, atherosclerosis, gout and uric calculous disease. Am J Clin Nutr, 1956, 4, 20-28.
Modan M, Halkin H, Almog S, et al. - Hyperinsulinemia : a link between hypertension, obesity and glucose intolerance. J Clin Invest, 1985, 75, 807-817.
Reaven GM. - Role of insulin resistance in human disease. Diabetes, 1988, 37, 1595-1607.
Kaplan NM. - The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med, 1989, 149, 1514-1520.
Scheen AJ. - Insulin resistance syndrome and atherosclerotic cardiovascular disease. Acta Clin Belg, 1996, 51, 65-69.
Scheen AJ. - Le syndrome X, à la croisée des maladies métaboliques et cardio-vasculaires. Rev Med Liège, 1998, 53, 29-32.
Groop L, Ohro-Melander M. - The dysmetabolic syndrome. J Intern Med, 2001, 250, 105-120.
Meigs JB. - Insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemol, 2000, 152, 908-911.
Scheen AJ, Luyckx FH. - Medical aspects of obesity. Acta Chir Belg, 1999, 99, 135-139.
Luyckx F, Scheen AJ, Gielen J, Lefèbvre PJ. - Comment j'explore ... Le syndrome d'insulinorésistance grâce à ses marqueurs biologiques. Rev Med Liège, 1997, 52, 686-691.
Luyckx FH, Scheen AJ, Desaive C, et al. - Effects of gastroplasty on body weight and related biological abnormalities in morbid obesity. Diabetes Metab, 1998, 24, 355-361.
Rantala AO, Kauma H, Lilja M, et al. - Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J Intern Med, 1999, 245, 163-174.
Alberti KGMM, Zimmet PZ for the WHO Consultation. - Definition, diagnosis and classification of diabetes mellitus and its complications. Part I, Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Med, 1998, 15, 539-553.
WHO consultation. - Definition, diagnosis and classification of diabetes mellitus and its complications. Part I, Diagnosis and classification of diabetes mellitus. World Health Organisation, non-communicable disease surveillance. Geneva, 1999.
Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. - Executive Summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA, 2001, 285, 2486-2497.
The European Group for the Study of Insulin Resistance (EGIR). - Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab, 2002, 28, 364-376.
Hollenbeck C, Reaven GM. - Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab, 1987, 64, 1169-1173.
Reaven GM. - Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med, 1993, 44, 121-131.
Isomaa B, Almgren P, Tuomi T, et al. - Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 2001, 24, 683-689.
Balkau B, Charles MA. - Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabetic Med, 1999, 16, 442-443.
Marques-Vidal P, Mazoyer E, Bongard V, et al. - Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers. Diabetes Care, 2002, 25, 1371-1377.
Ford ES, Giles WH, Dietz WH. - Prevalence of the metabolic syndrome among US adults. Findings from the third National Health and Nutrition Examination Survey. JAMA, 2002, 287, 356-359.
Ford ES, Giles WH. - A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care, 2003, 26, 575-581.
Després JP, Lamarche B, Mauriège P, et al. - Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med, 1996, 334, 952-957.
Lamarche B, Tchernof A, Mauriège P, et al. - Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA, 1998, 279, 1955-1961.
Lemieux I, Pascot A, Couillard C, et al. - Hypertriglyceridemic waist. A marker of the atherogenic metabolic triad (hyperinsulinemia, hyperapolipoprotein B, small dense LDL) in men? Circulation, 2000, 102, 179-184.
Lemieux I, Després JP - Obesity and hyperlipidemia. In: Management of obesity and related disorders (Kopelman PG, Ed). Martin Dunitz, London, UK, 2001, 45-63.
Belgian Association for the Study of Obesity (BASO). - Le consensus du BASO. Un guide pratique pour l'évaluation et le traitement de l'excės de poids. 2002.
EUROASPIRE II Study Group. - Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries: principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J, 2001, 22, 554-572.
Scheen AJ, Van Gaal LF, and OCAPI Investigators. - Need to optimize cardiovascular prevention in type 2 diabetic patients: the Belgian OCAPI Survey. Diabetologia, 2002, 45 (Suppl. 2), A63, 182.
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
